What DuPont de Nemours Doubters Overlooked

Simply Wall St.10-30 21:40

If DuPont de Nemours was sitting on your watchlist instead of in your account, the last twelve months may feel expensive. Investors who held DuPont de Nemours over the past year are up 39.9%, ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2679210216?lang=en_US&edition=fundamental","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/3061000-choice1-card/1788945898651","is_english":true,"pubTime":"2026-10-30 21:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2679210216","market":"sg","top_or_hot":-1,"title":"What DuPont de Nemours Doubters Overlooked","media":"Simply Wall St.","content":"<div>\n<p>If DuPont de Nemours was sitting on your watchlist instead of in your account, the last twelve months may feel expensive. Investors who held DuPont de Nemours over the past year are up 39.9%, ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/capital-goods/nyse-dd/dupont-de-nemours/news/what-dupont-de-nemours-doubters-overlooked\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What DuPont de Nemours Doubters Overlooked</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat DuPont de Nemours Doubters Overlooked\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-10-30 21:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/capital-goods/nyse-dd/dupont-de-nemours/news/what-dupont-de-nemours-doubters-overlooked><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If DuPont de Nemours was sitting on your watchlist instead of in your account, the last twelve months may feel expensive. Investors who held DuPont de Nemours over the past year are up 39.9%, ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/capital-goods/nyse-dd/dupont-de-nemours/news/what-dupont-de-nemours-doubters-overlooked\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4206","symbol_name":"工业集团企业","start_time":0,"source_url":"https://simplywall.st/stocks/us/capital-goods/nyse-dd/dupont-de-nemours/news/what-dupont-de-nemours-doubters-overlooked","article_id":"2679210216","we_media_id":null,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/3061000-choice1-card/1788945898651"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/capital-goods/nyse-dd/dupont-de-nemours/news/what-dupont-de-nemours-doubters-overlooked","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2679210216","pubTimestamp":1793367656,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"If DuPont de Nemours was sitting on your watchlist instead of in your account, the last twelve months may feel expensive. Investors who held DuPont de Nemours over the past year are up 39.9%, including dividends. That outcome raises a sharper question. Back on 29 October 2025, could a focus on electronics, healthcare and water, supported by specific revenue growth and margin assumptions, have helped you identify this setup before it occurred?\nThe useful thing about a Narrative is that the...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4206":"工业集团企业","LU0052756011.USD":"TEMPLETON GLOBAL BALANCED \"A\" (USD) INC","LU0128525689.USD":"TEMPLETON GLOBAL BALANCED \"A\"(USD) ACC","LU0310799852.SGD":"FTIF - Templeton Global Equity Income A MDIS SGD","BK4588":"碎股","DD":"杜邦","LU2236285917.USD":"ALLIANZ GLOBAL INCOME \"AMG\" (USD) INC","LU0211328371.USD":"TEMPLETON GLOBAL EQUITY INCOME \"A\" (MDIS) (USD)   INC","LU0310800965.SGD":"FTIF - Templeton Global Balanced A Acc SGD","BK4585":"ETF&股票定投概念","LU0211327993.USD":"TEMPLETON GLOBAL EQUITY INCOME \"A\" (USD) ACC","BK4504":"桥水持仓","LU1267930227.SGD":"TEMPLETON GLOBAL BALANCED \"AS\" (SGD) ACC A","BK4109":"特种化学制品","LU1267930490.SGD":"TEMPLETON GLOBAL EQUITY INCOME \"AS\" (SGD) INC A"},"translate_title":"杜邦·德·内穆尔怀疑者忽略了什么","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DD":1},"content_text":"If DuPont de Nemours was sitting on your watchlist instead of in your account, the last twelve months may feel expensive. Investors who held DuPont de Nemours over the past year are up 39.9%, including dividends. That outcome raises a sharper question. Back on 29 October 2025, could a focus on electronics, healthcare and water, supported by specific revenue growth and margin assumptions, have helped you identify this setup before it occurred? The useful thing about a Narrative is that the reasoning is checkable: the assumptions sit beside the argument, and together they imply an estimated Fair Value you can disagree with. DuPont de Nemours has already moved. Pinpoint other ways to investigate the theme among 36 healthcare AI stocks. AdvertisementThe Argument You Would Have Been Weighing Up On DuPont de Nemours The shares cost US$82.16 at the start of the period, which meant any decision on DuPont de Nemours hinged on which story about its future you found more convincing. The bullish narrative saw a focused electronics, healthcare and water specialist with a Fair Value of US$92.67, or 13% above the start price. That view leaned on 3.0% revenue growth assumptions and a 12.7% profit margin, supported by an expected future P/E of 27.9x over a 3 year window. The bearish story carried a Fair Value of US$47 and focused on concerns about long term ESG and PFAS burdens. That case highlighted rising environmental regulation and litigation as ongoing risks to profitability and future earnings growth for DuPont de Nemours. NYSE:DD 1-Year Stock Price Chart What The Results Changed For The DuPont de Nemours Story DuPont de Nemours posted Q2 2026 revenue of US$1,819m and net income of US$187m, up from US$1,749m and US$13m in Q2 2025, with net margin moving from 0.7% to 10.3%. That shift in profitability supported parts of the bullish electronics, healthcare and water thesis, while ongoing PFAS settlements and new ESG targets kept the cautious case alive. Overall, the evidence cut both ways. The decision back in October 2025 hinged on whether higher margins in refocused segments would actually show up in the accounts. For any other stock built on a similar profitability story, you would want to track changes in net margin alongside segment mix, rather than relying only on revenue or guidance headlines. What DuPont de Nemours Buyers Are Being Asked To Believe Now Today DuPont de Nemours trades at US$141, after a 39.9% gain over the past year. The selected Narrative still places its Fair Value above that level, based on a focused portfolio in healthcare, water and industrial applications. The argument leans on productivity programs, free cash flow and capital returns. A buyer now has to judge whether sustained 3% net productivity of COGS can keep offsetting cost pressures and environmental spend. \"Ongoing productivity programs that target 3% net productivity of COGS each year, coupled with already delivered COGS reductions and efforts to push cost of poor quality below the current 4% of sales, create room for further operating EBITDA margin expansion and earnings growth if execution continues.\" The price and this Narrative do not agree. → Uncover what this Narrative says DuPont de Nemours is actually worth Looking Beyond DuPont de Nemours Once you understand DuPont de Nemours, your eye can shift sideways to infrastructure. AI hardware still needs something more basic than specialty materials. All that processing power only matters if data centers stay online. Reliable power and cooling turn racks of chips into usable computing capacity. Another business concentrates on that plumbing behind the scenes. It builds systems that move heat away from equipment and keep electricity flowing. Instead of chemicals or membranes, its expertise is thermal control and uptime. As AI buildouts grow denser, that kind of backbone can shape what is possible. That argument has a Narrative and a number behind it. → See the company one Narrative values 66% above its price This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.1","shortVersion":"4.52.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2679210216","isCrawlerRequest":true}